Head-to-head · WeighScore
AHBARx vs Care Clinics
By GLP-1 ScorecardUpdated
Score comparison
Care Clinics has the higher recorded score — 85.4/100 to 64.2/100.
Care Clinics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medication-program prices and supply descriptions conflict; confirm the selected quote.
Before you choose
Care Clinics does not publish a semaglutide price, so its Care Clinics review sets out what it does disclose, while the AHBARx review explains the conditions attached to AHBARx's figure. The semaglutide cost page compares published rates across the field. Ask Care Clinics for a written total before treating either one as the cheaper choice.
If neither one fits, AHBARx vs CoreAge Rx and Alegro Health vs Care Clinics compare each of them with another graded program, and the list of alternatives to AHBARx ranks the programs closest to AHBARx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AHBARx | Care Clinics |
|---|---|---|
| WeighScore | 64.2/100 | 85.4/100 |
| Grade | C | B |
| Site position | #260 | #12 |
| Semaglutide | Selected quote required: 1-month selector shows $162 first order and $249 refill | Conflicting program/supply descriptions; confirm selected quote. |
| Tirzepatide | Selected quote required: 1-month selector shows $227 first order and $349 refill | Conflicting program prices; confirm selected quote and supply. |
| Coverage | Confirm eligibility for the selected treatment | FAQ lists 31 states plus DC; confirm medication-specific eligibility. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Public plan selectors show the first and repeat charges for each supply period
- The six-month offer separates the billing interval from the shipment interval
- Product pages say refills are reviewed during follow-up consultations
What to consider
- The terms describe a monthly weight-loss membership; the selector does not settle whether it adds a separate charge for a specific plan
- The cancellation terms contain unfinished contact and pharmacy placeholders
- The terms say unshipped medication will not be sent after cancellation; confirm how unused prepaid amounts are handled
- AnazaoHealth, named in the Help Center as a partner, is the subject of an FDA warning letter issued August 2021 to “AnazaoHealth Corporation” of Las Vegas, Nevada. It is a disclosure about a supplier; AHBARx carries no warning letter of its own
Strengths
- Published medication program totals
- Consultation-only prescription option described
What to consider
- Prices and supply descriptions conflict
- Refund and renewal conditions need confirmation
- Actual care and dispensing assignments require confirmation
- Independent current certification not established
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.